PD23-01: Utility of PROSTest, a novel blood-based mRNA assay, for predicting outcome to 177LuPSMA radioligand therapy
Sunday, May 17, 2026 3:30 PM to 3:38 PM · 8 min. (America/New_York)
206
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!